ORGAPRED, a France-based core facility specializing in Patient-Derived Tumor Organoid (PDTO) research, has selected the ...

Can Rett syndrome be treated with precision medicine? A new study using brain organoids shows that mutations R306C and V247X require different drugs, HDAC2 inhibitors and baclofen, to restore brain ...

Though many studies approach the developmental disorder Rett syndrome as a single condition arising from general loss of ...

This article explores innovations helping organoids reach their enormous potential. From vascularized tissues to fused ...

Though many studies approach the developmental disorder Rett syndrome as a single condition arising from general loss of function in the gene MECP2, a ...

Researchers develop patient-specific organoids from stem cells to assess chemotherapy toxicity across heart, liver, and ...

Scientists at Bambino Gesu Children’s Hospital in Rome have grown three-dimensional tumor models from pediatric brain cancer ...

Patient-derived organoids (PDOs) offer researchers a highly relevant, patient-reflective disease-model system, as organoids often mirror the drug-response profiles of the individuals from whom they ...

Development of patient-specific human organoids models for heart, liver, and kidney tissues ...